Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (otvara se novi prozor)

Ball AM, Winstead PS.

Izvor‎: Pharmacotherapy 2008;28(11):1383-90.

Indeks‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (otvara se novi prozor)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (otvara se novi prozor)

Charles A, Purtill M, Napolitano LM.

Izvor‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeks‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (otvara se novi prozor)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (otvara se novi prozor)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Izvor‎: N Engl J Med. 2023 2;389(18):1649-59.

Indeks‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (otvara se novi prozor)

Bloodless management of the anemic patient in the emergency department. (otvara se novi prozor)

Johnson-Arbor K, Verstraete R

Izvor‎: Ann Emerg Med 2022;79(1):48-57.

Indeks‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (otvara se novi prozor)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (otvara se novi prozor)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Izvor‎: J Trauma 2008;65(2):285-97.

Indeks‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (otvara se novi prozor)

Erythropoiesis in multiply injured patients. (otvara se novi prozor)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Izvor‎: J Trauma 2006;61(5):1285-91.

Indeks‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (otvara se novi prozor)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (otvara se novi prozor)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Izvor‎: Arch Surg 2012;147(3):251-5.

Indeks‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (otvara se novi prozor)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (otvara se novi prozor)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Izvor‎: Chirurg 2011;82(6):531-5.

Indeks‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (otvara se novi prozor)